Jul 23, 2021 11:42 AM IST
Adar Poonawalla is also the Chief Executive Officer of Serum Institute of India, which is manufacturing the Oxford-AstraZeneca vaccine (Covishield) against COVID-19.
- May 31, 2021 10:55 AM IST
Owing to vaccine shortage, in March, India had put a temporary hold on all major exports of the AstraZeneca coronavirus vaccine to meet demand at home as infections rise.
- May 25, 2021 10:57 PM IST
He and officials of the Pune Municipal Corporation met SII officials and also wrote to them seeking at least 25 lakh doses for the Pune city.
- May 19, 2021 05:37 PM IST
By August, suggest some experts, the situation will ease. July is the crucial month when indigenous production of vaccines will go up, as will imports
- May 19, 2021 02:26 PM IST
As the debate on allowing vaccine exports in the face of local shortage gains momentum, senior officials across key ministries say companies are free to honour their contractual obligations and sell abroad if they have enough doses
- May 18, 2021 10:33 AM IST
During a daily virtual press briefing on Monday, the World Health Organisation Director-General said that the surge in COVID-19 cases around the world has compromised the global vaccine supply and there is already a shortfall of 190 million doses to COVAX by the end of June.
- May 16, 2021 07:55 PM IST
Global tenders for vaccines issued by the Uttarakhand government and Mumbai’s civic body had also specifically barred companies from neighbouring countries.
- May 13, 2021 06:22 PM IST
While some municipalities are, or will issue tenders to procure vaccines, others are directly talking to manufacturers. The smaller provinces seem to be depending on distribution by the central government.
- Apr 29, 2021 11:51 AM IST
COVID-19 Second Wave Vaccine Drive: It has been a Covishield show so far as state governments make a beeline for developer SII’s office. Bharat Biotech needs to significantly ramp up capacity of Covaxin.
- Apr 25, 2021 06:46 PM IST
Former CEA Arvind Subramanian said that centre should bear entire cost of vaccine procurement by state. Other economists partly agree and say that part of the Rs 35,000 crore vaccination budget should be shared with states
- Apr 24, 2021 04:18 PM IST
"Covishield is the most affordable COVID-19 vaccine available in the market today. The initial prices were kept very low globally as it was based on advance funding given by those countries for at-risk vaccine manufacturing," Serum India said in a statement.
- Apr 23, 2021 11:16 AM IST
On April 19, the central government announced a major shift in its Covid-19 vaccination strategy. Moneycontrol takes a look at what these changes mean.
- Apr 20, 2021 08:39 PM IST
UNICEF also expects to receive 50 million doses of the shot from the Serum Institute of India in May, compared with almost none this month as the company tries to meet demand in its home country that is battling a huge jump in infections.
- Apr 09, 2021 08:08 AM IST
A million doses from the institute, which had already been delivered, have been sold on to other countries in the African Union.
- Apr 07, 2021 01:19 PM IST
Serum Institute CEO Adar Poonawala was speaking at the launch of the Network18 Sanjeevani – A Shot Of Life, a CSR initiative by Federal Bank.
- Mar 04, 2021 03:09 PM IST
The high court also asked the Centre to explain in affidavit the rationale behind keeping strict control over class of persons who can be vaccinated against COVID-19 currently as under the present system those above the age of 60 years or between 45 to 60 years with comorbidities can receive vaccination.
- Feb 15, 2021 06:44 PM IST
Prior to COVID-19 pandemic, India had been producing 60 percent of the world's vaccines for various diseases at an affordable rate.
- Feb 04, 2021 02:42 PM IST
Beximco is Bangladesh's exclusive distributor of the Oxford University-AstraZeneca shot that SII, the world's biggest vaccine manufacturer, is producing in bulk for low- and medium-income countries.
- Jan 18, 2021 09:13 AM IST
Serum Institute's Chief Executive Officer Adar Poonawalla said that exports of the COVID-19 vaccine doses will start only after local requirements are fully met.
- Jan 06, 2021 10:17 PM IST
The city government is creating a massive storage facility at the Rajiv Gandhi Super Speciality Hospital (RGSSH) and the police administration has been informed about the imminent arrival of the vaccine lot.
- Dec 11, 2020 08:32 AM IST
Vaccine rollout will throw up opportunities not just for the domestic pharmaceutical and healthcare industry but also the logistics value chain, right from vaccine production, delivery, storage and then the actual immunisation
- Jul 27, 2020 10:00 PM IST
About 6,000 health workers and high-risk individuals including those in close contact of COVID-19 patients have been enrolled in a clinical trial to determine if the recombinant Bacillus Calmette-Guerian (rBCG) can boost immunity to fight against the virus, the statement added.
- Apr 30, 2020 01:26 PM IST
The Serum Institute of India said on Tuesday it plans this year to produce up to 60 million doses of a potential vaccine against the new coronavirus that is under clinical trial in Britain.
- Apr 29, 2020 07:22 AM IST
Serum, the world's largest maker of vaccines by volume, is mass-producing the vaccine candidate developed by the University of Oxford, which started testing it on humans last week, and is a leader in the global race to develop an antidote to the novel coronavirus.
- Apr 26, 2020 03:40 PM IST
The Pune-based company has partnered with Oxford University as one of the seven global institutions manufacturing the vaccine.